Ehealth: Second Life Impacts Diabetes Education & Self-Management

Not Applicable

Completed

• Conditions: Type 2 Diabetes

• Registration Number: NCT01186965
• Lead Sponsor: Duke University

Brief Summary

The purpose of this study is to to develop and evaluate the feasibility, usability, and effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing interactive diabetes education, support, and resources.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2010-08-19
• Study First Submitted QC: 2010-08-20
• Study First Posted: 2010-08-23
• Study Start: 2011-01
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-04
• Last Update Posted: 2015-03-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• current Duke Endocrinology patient
• are between 21 and 75 years old
• are able to speak and read English
• are computer literate (have used a computer for at least 6 months)
• understand how to use the Internet (have accessed the Internet on at least 6 occasions)
• have access to a computer with a non-dial-up Internet connection in a private location (home)
• are mentally capable of informed consent
• are reachable by telephone
• have no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (i.e., physical activity) or measures (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or receipt of pharmacologic doses of anti-coagulant medications [warfarin])
• are able to travel to Duke University Medical Center (DUMC) for follow-up appointments.

Read More

Exclusion Criteria

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Process data	January 2011 through May 2012
Perceived Usefulness	3 and 6 months
Perceived Ease of Use	3 and 6 months

Secondary Outcome Measures

Name	Time	Method
Demographics	baseline
Metabolic Indicators	baseline, 3 months, 6 months
Diabetes knowledge	baseline, 3 months, 6 months

Trial Locations

Locations (1)

Duke University Medical Center; 🇺🇸 Durham, North Carolina, United States